Phytotech Medical Limited (ASX:PYL) Admission And Commencement Of Official Quotation

Sydney, Jan 20, 2015 - (ABN Newswire) - Phytotech Medical Limited (ASX:PYL) (Company) was admitted to the Official List of ASX Limited (ASX) on Tuesday, 20 January 2015.

Official quotation of the Company's securities will commence at 2:00 pm Australian Eastern Daylight Savings Time ("AEDST") on Thursday, 22 January 2015. The Company has raised $5,932,410 pursuant to the offer under the prospectus dated 20 November 2014 and supplementary prospectus dated 5 January 2015 issued by the Company (together the "Prospectus") by the issue of 29,662,050 ordinary shares at an issue price of $0.20 per share.

Quoted Securities: 34,462,050 fully paid ordinary shares

ASX Code: PYL
Time: 2pm AEDST
Date: Thursday, 22 January 2015
ASX Trade Abbreviation: PHYTOTECH
ISIN: AU000000PYL8

Home Branch: Perth
Industry Classification: 3520 Pharmaceuticals, Biotechnology & Life Sciences
Registered Office: Suite 9, 330 Churchill Avenue
SUBIACO WA 6008
Ph: (08) 6489 1600
F: (08) 6489 1601
E: info@phytotechmed.com
Company Secretary: Loren Jones
Share Registry: Automic Registry Services
Level 1, 7 Ventnor Avenue
WEST PERTH, WA 6005
Ph: (08) 9324 2099
F: (08) 9321 2337

Balance Date: 30 June

CHESS: Participating. The Company will also operate an issuer sponsored sub-register.

Place of Incorporation: Western Australia

Dividend Policy: See section 2.14 of the Prospectus

Activities: Research, development and commercialisation of medical cannabis delivery systems.

ASX Restricted Securities: 3,000,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow for a period of 24 months from the commencement of official quotation

7,200,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow for a period of 12 months from 17 September 2014

2,500,000 options exercisable at $0.20 on the date that is three years after the date of issue to be held in escrow for a period of 24 months from the commencement of official quotation

10,000,000 Class A performance rights as set out at page 93 of the Prospectus to be held in escrow for a period of 24 months from the commencement of official quotation

10,000,000 Class C performance rights as set out at page 93 of the Prospectus to be held in escrow for a period of 24 months from the commencement of official quotation

10,000,000 Class D performance rights as set out at page 93 of the Prospectus to be held in escrow for a period of 24 months from the commencement of official quotation

For further details, please refer to the Company's prospectus dated 20 November 2014 and supplementary prospectus dated 5 January 2015.

WEB: ASX Notice

About: Phytotech Medical Limited

Phytotech Medical (ASX:PYL) is a new company established to be an Australian pioneer in the development of Medical Cannabis Delivery Systems, initially to regulated medical cannabis markets in the USA, Canada, Israel and Europe, as well as Australia and New Zealand, which may become regulated at a future point in time.

Contact:
Jeremy Newman
T: +61-8-9224-0029

Phytotech
Ph: (08) 6489 1600
F: (08) 6489 1601
E: info@phytotechmed.com

Help employers find you! Check out all the jobs and post your resume.

Back to news